Skip to main content
OpenTrials
Completed

NCT Number: NCT01897935

Flare Photometry in Uveitis Patients

This is a cross sectional study of a novel non-invasive optical flare photometer (OFAM). Patients meeting the inclusion/exclusion criteria will receive a standard eye examination including a slit lamp examination to collect ocular flare data. In addition to the standard eye examination, subjects will receive flare measurements using the OFAM device.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Uveitis Eye Diseases Uveal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

UW Medicine Eye Institute

Seattle, Washington, 98195, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age greater than 18 years
  • Ability to understand and willingness to sign a written informed consent document.
  • To be eligible for the uveitis arm of the study subjects must have active anterior chamber uveitis in one or both eyes as determined by a physician
  • To be eligible for the non-inflammatory arm of the study the study subjects must have no ocular inflammation in either eye as determined by a physician.

Exclusion criteria

  • Inability to give informed consent
  • Exclusion criteria for the uveitis arm: no active disease
  • Exclusion criteria for the non-inflammatory arm: Signs of uveitis

Treatment and study plan

Primary outcomes

  1. Establish OFAM algorithms for quantitation of ocular flare

    Time frame: 3 months

    OFAM algorithms for quantitation of ocular flare will be established by comparing the output of the OFAM device to the flare measurements obtained during the standard slit lamp examination.

Secondary outcomes

  1. Determine the impact that various potential confounders such as age and sex have on OFAM Measurements

    Time frame: 3 months

    OFAM data for various sub-groups (age and sex) will be compared in order to evaluate the degree to which each sub-group acts as a confounder for OFAM measurements.

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

ChromoLogic, LLC

Industry

Collaborators

  • UW Medicine Eye Institute

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Jul 12, 2013
Registry last updated
May 1, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.